Free Trial

Calumet Specialty Products Partners (NASDAQ:CLMT) Raised to Neutral at UBS Group

Calumet Specialty Products Partners logo with Oils/Energy background
Remove Ads

UBS Group upgraded shares of Calumet Specialty Products Partners (NASDAQ:CLMT - Free Report) from a sell rating to a neutral rating in a research note published on Monday morning, Marketbeat.com reports. UBS Group currently has $12.00 price target on the oil and gas company's stock, down from their previous price target of $15.00.

CLMT has been the subject of a number of other research reports. StockNews.com raised Calumet Specialty Products Partners to a "sell" rating in a research note on Monday, November 18th. Wells Fargo & Company reduced their price target on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. HC Wainwright restated a "buy" rating and set a $33.00 price objective on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. Finally, TD Cowen lowered shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their target price for the stock from $26.00 to $16.00 in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $20.80.

Remove Ads

Check Out Our Latest Stock Report on Calumet Specialty Products Partners

Calumet Specialty Products Partners Trading Down 4.9 %

NASDAQ CLMT traded down $0.66 on Monday, hitting $12.72. 3,139,857 shares of the company were exchanged, compared to its average volume of 695,633. The company has a market cap of $1.09 billion, a PE ratio of -4.61 and a beta of 1.88. The stock has a fifty day moving average of $15.55 and a 200-day moving average of $18.65. Calumet Specialty Products Partners has a 12 month low of $9.97 and a 12 month high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. During the same period last year, the company earned ($0.59) EPS. Calumet Specialty Products Partners's revenue for the quarter was down 2.8% compared to the same quarter last year. On average, analysts expect that Calumet Specialty Products Partners will post -3.02 earnings per share for the current year.

Insider Buying and Selling at Calumet Specialty Products Partners

In other Calumet Specialty Products Partners news, CFO David Lunin acquired 2,500 shares of the company's stock in a transaction on Tuesday, March 4th. The shares were acquired at an average cost of $13.05 per share, with a total value of $32,625.00. Following the completion of the acquisition, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.91% of the stock is owned by corporate insiders.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Featured Articles

Analyst Recommendations for Calumet Specialty Products Partners (NASDAQ:CLMT)

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

While tech giants are down, "boring" bank stocks are quietly outperforming. Find out how to leverage these banks' stability for significant gains!

Related Videos

Why Palantir’s Future Just Got a Massive Boost
7 Flying Car Stocks to Buy Before the Sector Really Takes Off
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads